Search the Newsreel

Arcturus Therapeutics (ARCT) to Announce Quarterly Earnings on Thursday

Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026

STOCKHOLM, July 29, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the second quarter 2026, in conjunction with their partner Biogen's second quarter report. In total, sales of JPY 29.3 billion …

RedCloud Holdings plc (Nasdaq: RCT) hires veteran CFO David Sturgeon

RedCloud Holdings plc (Nasdaq: RCT) has appointed David Sturgeon as its new Chief Financial Officer, effective August 1, 2026. Sturgeon brings over three decades of international finance leadership, including nearly ten years as CFO for Nasdaq-listed companies, making him well-suited to guide RedCloud as …

Arcturus Therapeutics Holdings Inc (ARCT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Arcturus Therapeutics Holdings Inc (ARCT), detailing its volatility, financial risk, and investment risk. It highlights the company's current risk assessment score, its beta value compared to the S&P 500 index, and various financial metrics such as maximum …

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026

Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) announced it will release its second-quarter financial results for 2026 on Thursday, August 6th, after market close. The company will also host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to provide …

Arcturus Therapeutics Q2 Results: Financials and update due Aug 6

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is scheduled to release its Q2 2026 financial results after market close on August 6, 2026, followed by a conference call at 4:30 p.m. ET for a corporate update. While no specific financial figures are in the pre-announcement, …

Arcturus Therapeutics Market Sentiment

This article provides an overview of market sentiment for Arcturus Therapeutics (ARCT), including analyst consensus, short interest, options flow, and insider activity. Analysts have a "Buy" consensus with an average price target significantly higher than the current price, despite rising short interest. The report …

RedCloud Holdings Appoints David Sturgeon as Chief Financial Officer

RedCloud Holdings has announced the appointment of David Sturgeon as Chief Financial Officer, effective August 1, 2026. Sturgeon brings over 30 years of finance leadership experience, including nearly a decade as CFO for Nasdaq-listed companies, and is expected to play a crucial role in …

RedCloud’s Incoming CFO Has More Than 30 Years in Finance

RedCloud (Nasdaq: RCT) has appointed David Sturgeon as its Chief Financial Officer, effective August 1, 2026. Sturgeon brings over 30 years of international finance leadership experience, including nearly a decade as CFO at Nasdaq-listed companies and is a Fellow of the Institute of Chartered …

Arcturus' 4:30 p.m. webcast follows its Aug. 6 results release

RedCloud Holdings PLC (RCT) Balance Sheet

This article provides a detailed balance sheet for RedCloud Holdings PLC (RCT), offering quarterly and annual financial data spanning from FY2024Q2 to FY2025Q4. It includes key financial metrics for assets, liabilities, and shareholders' equity, allowing for analysis of the company's financial health and fundamental …

RedCloud Holdings plc Revenue Breakdown – NASDAQ:RCT

This page provides financial overview for RedCloud Holdings plc (NASDAQ: RCT) on TradingView. It offers access to financial statements, statistics, dividends, earnings, and segment performance breakdowns by source and country, sourced from ICE Data Services and FactSet. The article provides only metadata and navigation …

Arcturus Therapeutics Holdings Inc

This article provides details on Arcturus Therapeutics Holdings Inc (ARCT), including its current stock price and market capitalization. It highlights that revenue breakdown data by business segment and region has not yet been disclosed by the company. The page also offers general information about …

RedCloud Holdings PLC (RCT) Income Statement

This article provides RedCloud Holdings PLC's (RCT) income statement information, offering insights into its financial performance. It also includes an FAQ section explaining how to interpret income statements, differentiating between quarterly and annual reports, and defining key metrics like YOY and EPS. The company …

RedCloud Holdings PLC (RCT) Cash Flow

This article provides key cash flow information for RedCloud Holdings PLC (RCT), detailing its operating, investing, and financing cash flows, along with capital expenditures and free cash flow. It explains what each cash flow metric signifies for investors and provides RedCloud's specific figures, such …

Arcturus Therapeutics Holdings Inc (ARCT) Cash Flow

This article provides a detailed cash flow statement for Arcturus Therapeutics Holdings Inc (ARCT), covering quarterly and annual data from FY2012Q3 to FY2026Q1. It breaks down operating, investing, and financing cash flows, along with specific components like capital expenditures and changes in working capital. …

Arcturus Therapeutics Holdings Inc (ARCT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Arcturus Therapeutics Holdings Inc (ARCT) focusing on its dividend and stock split history. It states that the company has not distributed dividends over the past five years. Key financial data like market capitalization and recent stock performance are …

RedCloud Holdings PLC (RCT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of RedCloud Holdings PLC (RCT) stock and its dividend history. It states that no dividends have been distributed over the past five years. The page details the current stock price, market cap, and a general company overview.

RedCloud Holdings PLC (RCT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for RedCloud Holdings PLC (RCT), focusing on volatility, financial, and investment risks. It details various metrics such as Beta, VaR, Maximum Drawdown, Volatility, Return-to-Drawdown Ratio, Skewness, Realised Volatility, Downside Risk-Adjusted Return, and Liquidity. The data covers different timeframes, …

Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Arcturus Therapeutics Holdings Inc (ARCT), listing its major shareholders and institutional holdings. Key shareholders include Federated Hermes Global Investment Management Corp., ARK Investment Management LLC, and BlackRock Institutional Trust Company, N.A., alongside data on institutional shareholding trends …

RedCloud Holdings PLC (RCT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of RedCloud Holdings PLC (RCT), identifying its major individual and institutional holders. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activity with changes in holdings and proportions.

RCT|RedCloud Holdings PLC|Price:0.214|Chg%:+0.002

RedCloud Holdings PLC (RCT) is trading at $0.214, up 1.14%. The company's platform uses AI to facilitate trading of fast-moving consumer goods, serving a large network of distributors, brands, and retailers across multiple countries. Analysts have a "Strong Buy" rating with a target price …

RedCloud Holdings PLC (RCT) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in RedCloud Holdings PLC (RCT). It lists key shareholders and their holdings, highlighting changes in some positions. The data provides insights into significant institutional activity related to RedCloud Holdings PLC.

Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for Arcturus Therapeutics Holdings Inc. (ARCT) on NASDAQ, showing its current stock price and performance. It indicates that Arcturus Therapeutics' stock is down by 4.84% at $5.79, with delayed prices. The page also presents a lack of …

Reef Casino Trust Revenue Breakdown – ASX:RCT

ARCT|Arcturus Therapeutics Holdings Inc|Price:5.530|Chg%:-0.260

This article provides a financial summary of Arcturus Therapeutics Holdings Inc (ARCT), detailing its latest earnings report from May 7, 2026, and presenting historical quarterly and annual financial metrics. It covers key indicators such as EPS, revenue, net profit, various margins, and balance sheet …

Arcturus Therapeutics Holdings Inc. Revenue Breakdown – NASDAQ:ARCT

This article provides a revenue breakdown for Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT). Last year, the company generated $82.03 million USD, primarily from its Messenger Ribonucleic Acid Medicines segment, and the largest contribution came from the United States. This marks a decrease from $152.31 …

Why High Arctic Energy Services Inc. stock went up yesterday

Iris Eases Conditions on Off-Market Bid for Reef Casino Trust

RedCloud Holdings (RCT) adds $6.7M ATM facility as CFO resigns

RedCloud Holdings plc (RCT) has entered into an At The Market (ATM) Offering Agreement with H.C. Wainwright & Co., LLC, establishing a facility for the sale of ordinary shares with an aggregate market value of up to $6.7 million. Concurrently, CFO Raju Datla has …

Arcturus Therapeutics Holdings Inc (ARCT) Earnings, Actual EPS, EPS Estimates & Results

This article provides detailed earnings information for Arcturus Therapeutics Holdings Inc (ARCT), including its upcoming Q2 '26 earnings report, estimated EPS and revenue, and historical quarterly earnings data. It highlights past performance against estimates, showing both beats and misses. Additionally, the article includes recent …

RedCloud Holdings (RCT) reports 2025 material weaknesses in financial controls

RedCloud Holdings plc (RCT) filed an amended annual report for 2025, revealing that its disclosure controls and internal control over financial reporting were ineffective as of December 31, 2025. The company identified material weaknesses, including a lack of qualified full-time accounting and financial reporting …

RedCloud : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)

RedCloud Holdings plc has filed an Amendment No. 1 to their annual report on Form 20-F for the year ended December 31, 2025. This amendment specifically addresses Item 15, Controls and Procedures, identifying material weaknesses related to a lack of qualified accounting personnel and …

Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference

Arcturus Therapeutics Holdings Inc. announced it will present at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 12:00 p.m. ET. The company, an mRNA medicines developer, specializes in liver and respiratory rare disease therapeutics using LUNAR lipid-mediated delivery and …

Roth MKM Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20

Roth MKM has reiterated its Buy rating on Arcturus Therapeutics (ARCT.US) and maintained its target price at $20. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

What's Going On With High Arctic Energy Services Inc. Stock Wednesday?